Celgene Corp (CELG) Misses Q1 EPS by 5c; Reaffirms FY2012 Guidance
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q1 EPS of $1.08, $0.05 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.32 billion.
Celgene Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Celgene Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
